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Port site metastases after pelvic and para-aortic laparoscopic lymphadenectomy staging in cervix cancer. Case
report
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Background. Patients diagnosed with locally advanced cervical cancer need a correct evaluation of lymph node. The presence of
lymph node metastases is an important prognostic factor, which will determine the extent of the radiation ﬁeld. Surgical staging
by pelvic and aortocava laparoscopic lymphadenectomy is more accurate than clinical staging.
Objective. To report a case of squamous cell Cervix IVB carcinoma with metastases at the trocar site following laparoscopic
lymphadenectomy staging.
Case report. A 65 year old woman diagnosed with squamous cell Cervix carcinoma G3, with both parametrial involvement, FIGO
2008 stage IIB, and IVB after pelvic and para-aortic laparoscopic lymphadenectomy staging. PET CT at diagnosis showed lymph
node involvement in the right external iliac chain. Paraortic nodes were not involved. The patient underwent Helical Tomother-
apy IMRT including: Vagina, cervix, paracolpios, parametrium, ovaries, pelvic nodal areas (iliac, obturator, presacral, bilateral
paraortic and inguinal), up to a total dose 50.4Gy with a simultaneous boost of 57.96Gy to pathological pelvic adenopathies.
Subsequently, the patient received PDR Braquitherapy (30Gy) with a vagino–uterine applicator A PET-CT performed six months
after showed a soft tissue density nodule (1.6×1 cm) between muscle planes of the abdominal left wall, which seems to cor-
respond in physical examination with a palpable induration of 1–2 cm under scar laparoscopy. FNA conﬁrmed the presence of
subcutaneous metastases of Cervical Cancer. The patient underwent surgery resection of the nodule following by External Beam
Radiation Therapy on tumor bed up to a total dose 50Gy.
Conclusion. One of the problems of laparoscopic lymphadenectomy is the tumor seeding at the trocar portals, and although the
frequency is unknown, it has been reported in both gynecological tumors (ovary, cervix) and no gynecological (gallbladder, kidney,
colon, stomach).
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Purpose/Objective. The aim of this study was to evaluate the qualitative response using post-therapy molecular imaging with [18F]
Fluorodeoxyglucose (FDG) PET/CT and to compare it with clinical response in patients with locally advanced cervical carcinoma
treated with radio-chemotherapy followed by brachytherapy.
Material and methods. This was a prospective cohort study of 27 patients with stage IB2-stage IIIB with new diagnosis of cervical
carcinoma who underwent pre- and post-treatment whole-body FDG-PET/CT. All patients were treated with external beam radio-
therapy and concurrent chemotherapy followed by high-dose rate (HDR) brachytherapy between August 2009 and August 2012.
Median age was 50 years (31–79). Post-therapy FDG-PET/CT was performed with a median of 13 weeks (11–20) after completing
brachytherapy. The qualitative results persistent or negative of PET/CT pre and post-therapy were recorded by 2 independent
observers and correlated with clinical response at the same time. Median follow-up was 19 months (7–33).
Results. Clinical assessment after treatment showed complete response in 18/27, local persistence in 1/27 and partial response
in 8/27. The post-therapy PET/CT showed persistent FDG uptake in 7/27 and was negative in 20 cases. 1/7 persistent uptake
correlated well with clinical ﬁndings, while 3/7 still showed partial response and the remaining 3, complete response. In 2 cases
PET/CT showed new sites of increased FDG uptake that were distant metastases. One of them presented negative uptake in
cervix whereas the other one had persistent uptake in cervix.
Conclusion. FDG-PET is a valuable tool to evaluate local response, correlates well with clinical ﬁndings. Post-therapy persistent
FDG uptake might be predictive of clinical persistent loco regional disease and can detect unsuspected distant metastases.
Increasing evidence has documented the value of FDG-PET/CT in Oncology, but only limited data comparing PET ﬁndings pre
and post-treatment with clinical response in patients with cervical carcinoma is available.
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Introduction/Purpose. Primary vaginalmelanoma is rare, but biologically aggressive. It affects elderlywomen and represents almost
3% of all vaginal tumors and about 1% of melanoma diagnosed in women. Its estimated incidence is 0.026 per 100,000 women a
